Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$10.94M
Net Profit Margin
-620.70%
TTM Avg
-326.13%
3Y Avg
-2493.66%
5Y Avg
-2115.74%
Market Cap
$10.92M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.59M
Net Profit Margin
0.00%
TTM Avg
-496.48%
3Y Avg
-440.58%
5Y Avg
-356.69%
Market Cap
$10.59M
Net Profit Margin
-2406.00%
TTM Avg
-2017.47%
3Y Avg
-5077.56%
5Y Avg
-6322.50%
Market Cap
$10.96M
Net Profit Margin
-666037.76%
TTM Avg
-148948.78%
3Y Avg
-148948.78%
5Y Avg
-148948.78%
Market Cap
$10.57M
Net Profit Margin
-141.28%
TTM Avg
-101.58%
3Y Avg
-179.50%
5Y Avg
-204.48%
Market Cap
$10.56M
Net Profit Margin
-14621.00%
TTM Avg
-5877.48%
3Y Avg
-2938.74%
5Y Avg
-1959.16%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polyrizon Ltd. (PLRZ) | $10.83M | N/A | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $10.94M | -620.70% | -326.13% | -2493.66% | -2115.74% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioVie Inc. (BIVI)vs › | $11.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.59M | 0.00% | -496.48% | -440.58% | -356.69% |
| Pluri Inc. (PLUR)vs › | $10.59M | -2406.00% | -2017.47% | -5077.56% | -6322.50% |
| Caring Brands, Inc. (CABR)vs › | $10.96M | -666037.76% | -148948.78% | -148948.78% | -148948.78% |
| Lifeward Ltd. (LFWD)vs › | $10.57M | -141.28% | -101.58% | -179.50% | -204.48% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | -14621.00% | -5877.48% | -2938.74% | -1959.16% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 0.00% | 11.23% | 5.62% | -9479.86% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-06-30 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-06-30 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | 0.00% |
